These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6670232)

  • 1. [Clinical and immunologic characteristics of arthritis of different etiologies].
    Mikunis RI; Kozlova TV
    Vrach Delo; 1983 Dec; (12):33-5. PubMed ID: 6670232
    [No Abstract]   [Full Text] [Related]  

  • 2. The HLA system and the rheumatic diseases.
    Marcelli-Barge A; Legrand L; Poirier JC; Schmid M; Dausset J
    Eur J Rheumatol Inflamm; 1982; 5(4):406-22. PubMed ID: 6983960
    [No Abstract]   [Full Text] [Related]  

  • 3. The concentrations of the fourth component of complement and of the C1 inactivator in synovial fluid from arthritic patients.
    Hedberg H; Laurell AB
    Clin Exp Immunol; 1972 Jun; 11(2):201-7. PubMed ID: 5040309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical spectrum of HLA-B27 related rheumatic diseases in India.
    Malaviya AN; Mehra NK; Adhar GC; Jindal K; Bhargava S; Batta RK; Vaidya MC; Tandon RK; Sankaran B
    J Assoc Physicians India; 1979 Jun; 27(6):487-92. PubMed ID: 528505
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on synovial fluid in arthritis. I. The total complement activity. II. The occurrence of mononuclear cells with in vitro cytotoxic effect.
    Hedberg H
    Acta Med Scand Suppl; 1967; 479():1-137. PubMed ID: 4172267
    [No Abstract]   [Full Text] [Related]  

  • 6. [Human leukocyte B27 antigen in patients with seronegative arthritis].
    Mladenović V; Kecman-Prunić B; Susaković N; Stolić I
    Srp Arh Celok Lek; 1983 Jun; 111(6):733-40. PubMed ID: 6607538
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our current experience in the detection of serum rheumatoid factors by immunofluorescence].
    Eshougues JR; Biserte G; Delcambre B; Leonardelli J; Flamencourt P
    Rev Rhum Mal Osteoartic; 1973; 40(7):491-6. PubMed ID: 4585619
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histocompatibility antigens in rheumatic diseases (proceedings)].
    Schattenkirchner M; Schürer W; Diem K; Scholz S; Albert ED
    Z Rheumatol; 1976; 35 Suppl 4():suppl 368-72. PubMed ID: 983393
    [No Abstract]   [Full Text] [Related]  

  • 9. HL-A27 and arthritis.
    Isomäki H; Koota K; Martio J; Nissilä M; Tilikainen A
    Ann Clin Res; 1975 Jun; 7(3):138-45. PubMed ID: 1190699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes in patients with chronic polyarthritis and extra-articular complications. Prospective long-term study].
    Knüsel O; Fehr K; Lambert PH; Zubler RH; Böni A
    Schweiz Med Wochenschr; 1979 Nov; 109(42):1584-93. PubMed ID: 316930
    [No Abstract]   [Full Text] [Related]  

  • 11. Antinuclear factors and chronic articular inflammation.
    Zvaifler NJ; Martinez MM
    Clin Exp Immunol; 1971 Feb; 8(2):271-8. PubMed ID: 4929777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration of increased influenza-A-antibody levels in the serum of patients with chronic polyarthritis].
    Wruck K; Zöller B; Faust-Tinnefeldt G; Engel HJ
    Z Rheumatol; 1985; 44(6):259-62. PubMed ID: 4096127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathological alterations in patients with seronegative spondarthritis.
    Kapoor AK; Singh GK; Khan IU; Bhushan V; Siddiqui JS
    Indian J Med Res; 1984 Jun; 79():831-5. PubMed ID: 6519708
    [No Abstract]   [Full Text] [Related]  

  • 14. The HL-A B27 histocompatibility antigen in rheumatoid arthritis variants.
    Gray RG; Gottlieb NL
    J Fla Med Assoc; 1976 May; 63(5):339-44. PubMed ID: 1262846
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired mixed leucocyte reaction in some different diseases, notably multiple sclerosis and various arthritides.
    Hedberg H; Källén B; Löw B; Nilsson O
    Clin Exp Immunol; 1971 Aug; 9(2):201-7. PubMed ID: 5570678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatic disorders in a HLA B27 positive population.
    Veys EM; Mielants H; Poriau S; Verbruggen G; van der Jeught J; Dhondt E; Goethals L
    Acta Rhumatol; 1979; 3(2):176-89; discussion 189-90. PubMed ID: 11496655
    [No Abstract]   [Full Text] [Related]  

  • 17. Antinuclear factors in synovial fluids.
    MacSween RN; Dalakos TK; Jasani MK; Wilson ME; Boyle JA; Buchanan WW; Goudie RB
    Lancet; 1967 Feb; 1(7485):312-4. PubMed ID: 4163515
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparability of adjuvant disease of rats with human diseases].
    Schmidt K; Ott VR
    Schweiz Med Wochenschr; 1973 Aug; 103(31):1099-103. PubMed ID: 4796194
    [No Abstract]   [Full Text] [Related]  

  • 19. [The HL-A W27 antigen. Its incidence in ankylosing spondylarthritis and the Fiessinger-Leroy-Reiter syndrome].
    Amor B; Feldmann JL; Delbarre F; Hors J; Beaujan MM; Dausset J
    Nouv Presse Med; 1974 May; 3(21):1373-4. PubMed ID: 4849973
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Histocompatibility antigen (HL-A 27) and its relation to disease.
    Brewerton DA; Cafrey M; Nicholls A; James DC
    Ann Rheum Dis; 1974 Jul; 33(4):406-7. PubMed ID: 4415268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.